The ROADMAP event at this year’s CTAD meeting in Barcelona represented the culmination of two years of efforts undertaken by a dedicated group of scientists under the auspices of the IMI framework with the common objective of highlighting Alzheimer’s disease care needs by conducting a comprehensive assessment of the real-world data available across the spectrum of Alzheimer’s disease in Europe.